Natural Fungal Fermentation Broth of Scleroderma bovista Ameliorates Ulcerative Colitis by Suppressing the NF-κB Pathway and Gut Microbial Dysbiosis

Scleroderma bovista fermentation broth (SBF) exhibits anti-inflammatory activity, but its effect on ulcerative colitis (UC) remains unclear. LC-MS/MS analysis revealed that SBF contains 43 compounds, including sclerocitrin homologs, cyclic peptides, and alkaloids. In vitro, SBF (20–40 μg/mL) promoted cell viability in LPS-stimulated RAW264.7 macrophages, suppressed nitric oxide overproduction, reduced iNOS, IL-1β, and COX-2 expression, and upregulated IL-10 mRNA expression. In vivo, in a dextran sulfate sodium (DSS)-induced colitis model, SBF (50–200 mg/kg) dose-dependently mitigated DSS-induced weight loss, disease activity, splenomegaly, colon shortening, crypt damage, and representative images suggested a reduction in macrophage infiltration. The highest dose (SBF200) showed efficacy comparable to that of 5-ASA. Mechanistically, SBF reduced colonic IL-1β, TNF-α, and IL-6 levels and inhibited NF-κB activation by decreasing phosphorylated IκBα and p65. Colonic IL-10, which was elevated in DSS-treated mice, was lower in SBF groups than in the 5-ASA group. Furthermore, 16S rRNA sequencing showed that SBF lowered the DSS-elevated Shannon index and shifted the PCoA profiles of colitic mice toward the control group. At the genus level, SBF treatment further enriched Akkermansia (already elevated in DSS mice compared with controls) and increased Faecalibaculum, while reducing the relative abundance of Turicibacter, Clostridium, and Enterococcus; Ligilactobacillus was only partially restored and remained below control levels. Thus, SBF prophylactically mitigates DSS-induced colitis by suppressing inflammation, inhibiting NF-κB signaling, and modulating the gut microbiota, supporting further investigation of SBF as a potential fungal-derived candidate for UC treatment.

Authors

Institutions

Publication Details

Journal
Microorganisms
Published
2026-11-18
DOI
https://doi.org/10.3390/microorganisms14112673
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Natural Fungal Fermentation Broth of Scleroderma bovista Ameliorates Ulcerative Colitis by Suppressing the NF-κB Pathway and Gut Microbial Dysbiosis

Yunqing Cheng, Xinuo Li, Jianfeng Liu, Min Zhang et al.
1 links
Microorganisms
Inflammatory Bowel Disease
article

Natural Fungal Fermentation Broth of Scleroderma bovista Ameliorates Ulcerative Colitis by Suppressing the NF-κB Pathway and Gut Microbial Dysbiosis

Yunqing Cheng, Xinuo Li, Jianfeng Liu, Min Zhang, Yang Ying, Siqi Yang, Hongli He, Xianjun Feng
article en

Abstract

Scleroderma bovista fermentation broth (SBF) exhibits anti-inflammatory activity, but its effect on ulcerative colitis (UC) remains unclear. LC-MS/MS analysis revealed that SBF contains 43 compounds, including sclerocitrin homologs, cyclic peptides, and alkaloids. In vitro, SBF (20–40 μg/mL) promoted cell viability in LPS-stimulated RAW264.7 macrophages, suppressed nitric oxide overproduction, reduced iNOS, IL-1β, and COX-2 expression, and upregulated IL-10 mRNA expression. In vivo, in a dextran sulfate sodium (DSS)-induced colitis model, SBF (50–200 mg/kg) dose-dependently mitigated DSS-induced weight loss, disease activity, splenomegaly, colon shortening, crypt damage, and representative images suggested a reduction in macrophage infiltration. The highest dose (SBF200) showed efficacy comparable to that of 5-ASA. Mechanistically, SBF reduced colonic IL-1β, TNF-α, and IL-6 levels and inhibited NF-κB activation by decreasing phosphorylated IκBα and p65. Colonic IL-10, which was elevated in DSS-treated mice, was lower in SBF groups than in the 5-ASA group. Furthermore, 16S rRNA sequencing showed that SBF lowered the DSS-elevated Shannon index and shifted the PCoA profiles of colitic mice toward the control group. At the genus level, SBF treatment further enriched Akkermansia (already elevated in DSS mice compared with controls) and increased Faecalibaculum, while reducing the relative abundance of Turicibacter, Clostridium, and Enterococcus; Ligilactobacillus was only partially restored and remained below control levels. Thus, SBF prophylactically mitigates DSS-induced colitis by suppressing inflammation, inhibiting NF-κB signaling, and modulating the gut microbiota, supporting further investigation of SBF as a potential fungal-derived candidate for UC treatment.

MicroorganismsVol. 14(11)
Jilin Normal University (CN)
Natural Science Foundation of Jilin Province
Good health and well-being
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon